Marisa Lana

A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)

Ly-Mee Yu, Simon Douglas, Clive Ballard, 2008, PLoS medicine.

Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities

J. O'Brien, A. Swann, C. Ballard, 2002, International journal of geriatric psychiatry.

Quality of Life for People With Dementia Living in Residential and Nursing Home Care: The Impact of Performance on Activities of Daily Living, Behavioral and Psychological Symptoms, Language Skills, and Psychotropic Drugs

J. O'Brien, C. Ballard, A. Swann, 2001, International Psychogeriatrics.

A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.

Alan J. Thomas, J. O'Brien, A. Swann, 2004, The Journal of clinical psychiatry.

Placement of dementia sufferers in residential and nursing home care.

C. Ballard, G. Wilcock, A. Fairbairn, 1998, Age and ageing.